Company Profile

TATVA CHINTAN PHARMA CHEM LTD.

NSE : TATVABSE : 543321ISIN CODE : INE0GK401011Industry : ChemicalsHouse : Private
BSE2489.75-25.95 (-1.03 % )
PREV CLOSE (Rs.) 2515.70
OPEN PRICE (Rs.) 2550.90
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 4711
TODAY'S LOW / HIGH (Rs.)2460.35 2550.90
52 WK LOW / HIGH (Rs.)2000.75 2975.55
NSE2490.05 -26.8 (-1.06 % )
PREV CLOSE(Rs.) 2516.85
OPEN PRICE (Rs.) 2533.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 2490.05 (74 )
VOLUME 55129
TODAY'S LOW / HIGH(Rs.) 2452.85 2545.95
52 WK LOW / HIGH (Rs.)2001 2977.8

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.00
TTM EPS (Rs.) 23.17
P/E Ratio 107.45
Book Value (Rs.) 199.17
Face Value (Rs.) 10
MCap (Rs. in Mn) 55185.46
Price/Earning (TTM) 95.00
Price/Sales (TTM) 18.95
Price/Book (MRQ) 12.50
PAT Margin (%) 17.64
ROCE (%) 27.88
Incorporation Year : 1996

Management Info :

- Chairman Chintan Nitinkumar Shah - Managing Director

Registered Office :

Address : Plot No 502/17,Gidc Estate,Ankleshwar Gidc,
Bharuch,
Gujarat-393002

Phone : 026-46253593/75730 46951/75730 46952

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
03Dec12-03-2021$ Outcome Of Board Meeting & Intimation For Appointment Of CFO Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Outcome Of Board Meeting &
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 as amended, we wish to inform that based on recommendation of the Nomination and Remuneration Committee (NRC), the Board of Director of the Company at its meeting held on Friday, 03 December 2021, has appointed Mr Ashok Bothra (Chartered Accountant) as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company with effect from 03 December 2021. The disclosure required under Regulation 30 of SEBI (LODR) Regulations, 2015 read with para A of Part A of Schedule III of the said regulations and read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09 September 2015 is enclosed in Annexure-1 Kindly take the above disclosure on your records.
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015..
30Nov11-30-2021$Tatva Chintan Pharma Chem acquires industrial land in Gujarat Tatva Chintan Pharma Chem ac

Tatva Chintan Pharma Chem has acquired an industrial land admeasuring 50,399.16 Sq. mtr at Dahej-III GIDC Estate, Bharuch, Gujarat, India. The above land has been acquired from internal accruals only and it will be used on need basis in future.

Tatva Chintan Pharma Chem is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals.

Tatva Chintan Pharma Chem has acquired an industrial land admea..
02Nov11-02-2021$ Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Announcement under Regulati
Dear Sir/Madam, Sub: Intimation of Schedule of Analyst/ Institutional Investor meeting. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby submit schedule of analyst/institutional investors meeting that the Company would be participating: Date Particulars Type Mode 01 November 2021 Axis Mutual Fund One on One Virtual Please note that the above shall be subject to changes, if any. Kindly take the above disclosure on your records.
Dear Sir/Madam, Sub: Intimation of Schedule of Analyst/ Instit..
28Oct10-28-2021$Tatva Chintan Pharma Chem informs about monitoring agency report Tatva Chintan Pharma Chem in
Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Tatva Chintan Pharma Chem has informed that it enclosed a copy of the Monitoring agency report of the Company for the quarter ended 30 September 2021, issued by ICICI Bank, appointed to monitor the utilization of proceeds of an Initial Public Offering ('IPO') of the Company.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 32(6) of SEBI (Listing Obligations and D..
28Oct10-28-2021$ Announcement under Regulation 30 (LODR)-Monitoring Agency Report Announcement under Regulati
Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed a copy of the Monitoring agency report of the Company for the quarter ended 30 September 2021, issued by ICICI Bank Limited, appointed to monitor the utilization of proceeds of an Initial Public Offering ('IPO') of the Company. Request you to please take the above on record.
Pursuant to Regulation 32(6) of SEBI (Listing Obligations and D..
Financials More
Rs. in Millions
QTR Sep 21 ANNUAL
Net Profit307.18
Gross Profit 335.52
Operating Profit 368.33
Net Sales
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Polson (BSE)
 13000.00 (8.33%)
M.Cap ( in Cr)
156.00
Privi Speciality Che (BSE)
 1959.25 (12.11%)
M.Cap ( in Cr)
7653.36
Atul (BSE)
 9073.60 (1.20%)
M.Cap ( in Cr)
26846.11
Yasho Industries (BSE)
 1310.00 (3.42%)
M.Cap ( in Cr)
1493.30
Balaji Amines (BSE)
 3317.40 (1.15%)
M.Cap ( in Cr)
10748.71
Shareholding Pattern More
NON-INSTITUTION 9.94 %
PROMOTERS 79.17 %
MUTUAL FUNDS/UTI 6.79 %
FI/BANKS/INSURANCE 0.57 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes